Open AccessCovid-19 Vaccination in India
Author(s) -
Karan Turbhekar,
Aditya Srivastava
Publication year - 2022
Publication title -
international journal for research in applied science and engineering technology
Language(s) - English
Resource type - Journals
ISSN - 2321-9653
DOI - 10.22214/ijraset.2022.41350
Subject(s) - covid-19 , vaccination , license , virology , medicine , veterinary medicine , political science , outbreak , infectious disease (medical specialty) , law , disease
Since 16 January 2021, India has administered more than 1.24 billion doses of COVID-19 vaccines. As of 30 November 2021, India has administered more than 1.3 billion doses overall, including the first and second doses of currentlyapproved vaccines. Oxford–AstraZeneca vaccine (manufactured under license by Serum Institute of India under the trade name Covishield) and Covaxin (developed locally by Bharat Biotech) were initially approved by India. Keywords: Covid-19 Vaccine, Covishield, Covaxin